Sector Alpha Week of 2026-09-11
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-11

Relaxo Footwears Ltd

RELAXO
Footwear

Relaxo Footwears Ltd is coiled. The quarters are improving, yet the P/E sits at the 5th percentile of its own 11-year range — the business is moving before the market.

The sharpest disagreement: annual EPS moved +5.3% against a −33.6% price move — the market has not yet caught up with the delivery.

The price is in a confirmed uptrend (6 weeks in) while the P/E sits at the 5th percentile of its own 11-year range. Underneath, the last four quarters read improving — profit +12.2% year on year, and 180% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Improving
fundamental trajectory, 12 quarters
Price
₹325
−33.6% 1Y
P/E
43.6×
5th pctile
of its own 11-year range
Revenue (Jun 26)
₹705 Cr
+7.8% YoY
Profit (Jun 26)
₹55.0 Cr
+12.2% YoY
Operating margin
15.0%
flat YoY
ROCE
11%
FY26
ROIC
7.5%
vs WACC 12.0% → −4.5 pp
Cash conversion
180%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Relaxo Footwears Ltd trades at ₹325, in a confirmed uptrend and 6 weeks into that stage. That is −13.6% against its own 200-day average. It sits at 40% of a 52-week range of ₹250 to ₹440. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (3 weeks and counting).

Today the stock is in a confirmed uptrend — week 6 of stage 2, confirmed. At ₹325 it trades −13.6% versus its 200-day average and sits at 40% of its 52-week range (₹250–₹440).

Sep 26: ₹325 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−13.6% versus the 200-day line, week 6 of stage 2
Price50-day avg200-day avg
S3S4₹978₹783₹587₹391₹196₹325₹376Sep 23Jun 24Mar 25Jan 26Sep 26
S3S4₹978₹783₹587₹391₹196₹325₹376Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (555 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +68% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (3 weeks and counting; last ahead the week of 2026-08-21) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Relaxo Footwears Ltd trades at 43.6× P/E, near the bottom of its own range — cheaper only 5% of the time. Its long-run median P/E is 67.1×, measured across 10.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 43.6× is near the bottom of its own range — cheaper only 5% of the time, against a long-run median of 67.1× measured over 10.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 43.6× vs a 67.1× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.5-year window; loss-period spikes above 139× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 5% of the time
P/EMedianEPS (TTM) (quarterly)
146.7×₹13.0117.1×₹9.787.5×₹6.557.9×₹3.228.3×₹0.0×43.70×₹7Mar 16Nov 18Jun 21Feb 24Sep 26
146.7×₹13.0117.1×₹9.787.5×₹6.557.9×₹3.228.3×₹0.0×43.70×₹7Mar 16Jun 21Sep 26
PEG 6.47 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Computed here as quarter-end P/E ÷ trailing-twelve-month EPS growth (only quarters with positive growth), because a reported quarterly PEG is not held for this stock. Last 4 quarters; values above 6 pinned at the top.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
6.4×5.0×3.5×2.0×0.6××6.00×Q3 FY24Q4 FY24Q4 FY26
6.4×5.0×3.5×2.0×0.6××6.00×Q3 FY24Q4 FY24Q4 FY26
P/E
43.6×
5th percentile of 11y
PEG
2.48
derived from 3-year earnings growth

Why the multiple sits where it does: over the past year annual EPS moved +5.3% against a −33.6% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the −22.7%/yr price move, ~−9.1%/yr came from earnings growth and ~−13.6 pp from the multiple (compressing); over 10y, of the +4.1%/yr price move, ~+4.2%/yr came from earnings growth and ~−0.1 pp from the multiple (roughly flat). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Improving

Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Relaxo Footwears Ltd reads as improving on its fundamental arc. Improving — profit growth bottomed 5 quarters ago at −13.4% and has held its recovery at +6.3%, ROCE holding at 11.1%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue −3.2% in FY26, profit +5.3% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
21%40%14%20%7.4%0.0%0.6%−20%−6.2%−39%%%−3.2%5.3%FY16FY21FY26
21%40%14%20%7.4%0.0%0.6%−20%−6.2%−39%%%−3.2%5.3%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit accelerating
RevenueProfitEPS
9.3%35%4.6%22%−0.2%8.1%−5.0%−5.3%−9.7%−19%%%2.2%6.3%6%Sep 23Dec 24Jun 26
9.3%35%4.6%22%−0.2%8.1%−5.0%−5.3%−9.7%−19%%%2.2%6.3%6%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
15%14%13%12%11%%11.1%Sep 23Mar 24Dec 24Sep 25Jun 26
15%14%13%12%11%%11.1%Sep 23Dec 24Jun 26
Revenue growth
Recovering
latest +2.2% · span −8.4% to +8.0%
Profit growth
Flat
latest +6.3% · span −15.0% to +31.2%
EPS growth
Flat
latest +6.0% · span −15.0% to +31.3%
ROCE
Stuck low
latest 11.1% · span 10.8%–14.5%

Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue−3.2%−1.0%+2.8%+4.9%
Profit+5.3%+5.1%−9.3%+4.1%
EPS+5.3%+5.1%−9.3%+3.7%
Share price−33.6%−29.4%−22.7%+4.1%
Revenue YoY (Jun 26)
+7.8%
latest quarter vs a year ago
Profit YoY (Jun 26)
+12.2%
latest quarter vs a year ago
Revenue 10y
4.9%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

30.1/100 — rank 7 of 7 in Footwear · 100% evidence confidence

Relaxo Footwears Ltd scores 30.1 out of 100 against the 7 companies it is compared with in Footwear, ranking 7. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 13.3 + 11.6 + 2.9 + 2.3 = 30.1. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Relaxo Footwears Ltd reported ₹705 Cr of revenue in the Jun 26 quarter, +7.8% year on year. That is the 3rd straight quarter of year-on-year growth. Over 10 years it has compounded at 4.9% a year. The last full year, FY26, came in at ₹2,702 Cr. The last four reported quarters add to ₹2,753 Cr.

FY26 revenue came in at ₹2,702 Cr (−3.2% on the year), capping 10 years at 4.9% compound. The latest quarter (Jun 26) printed ₹705 Cr, +7.8% year on year — the 3rd consecutive quarter of year-over-year growth.

FY26 revenue ₹2,702 Cr (−3.2% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
4.9% a year over 10 years
RevenueYoY growth
3.1k21%2.4k14%1.6k7.4%7870.6%0−6.2%₹ Cr%₹2,702−3.2%FY16FY21FY26
3.1k21%2.4k14%1.6k7.4%7870.6%0−6.2%₹ Cr%₹2,702−3.2%FY16FY21FY26
Jun 26: ₹705 Cr (+7.8% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
3rd straight quarter of growth
Revenue (quarterly)YoY growth
8119.8%6083.8%406−2.3%203−8.3%0−14%₹ Cr%₹7057.8%Sep 23Dec 24Jun 26
8119.8%6083.8%406−2.3%203−8.3%0−14%₹ Cr%₹7057.8%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged +2.1% growth against the decade's 4.9% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +2.2% over the last 4 quarters against −3.0%/yr over the last 8 — accelerating; TTM profit +6.3% vs −0.5%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Relaxo Footwears Ltd's operating margin is 15.0% in the Jun 26 quarter, +0.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 12.0% to 21.0%. The current quarter sits inside that band.

The latest quarter's operating margin is 15.0%, +0.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 12.0%–21.0%.

Why the margin moved: operating margin went +0.2 pp year on year while gross margin went +4.8 pp — the gain came mostly from the gross line: input costs and pricing.

FY26: 14.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 12.0–21.0% band over 13 years
operating marginYoY change (pp)
22%4.7%19%2.1%17%−0.5%14%−3.1%11%−5.7%%%14%0%FY14FY20FY26
22%4.7%19%2.1%17%−0.5%14%−3.1%11%−5.7%%%14%0%FY14FY20FY26
Jun 26: 15.0% operating margin (+0.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
18%2.3%16%1.2%14%0.0%11%−1.2%9.4%−2.3%%%15%0%Sep 23Dec 24Jun 26
18%2.3%16%1.2%14%0.0%11%−1.2%9.4%−2.3%%%15%0%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Relaxo Footwears Ltd earned ₹55.0 Cr of net profit in the Jun 26 quarter, +12.2% year on year. It is the 2nd consecutive quarter of growth. Full-year FY26 profit was ₹179 Cr. The 10-year compound rate is 4.1%. That is 7.8% of the quarter's revenue. The same quarter a year earlier earned ₹49.0 Cr.

Jun 26 profit was ₹55.0 Cr, +12.2% year on year — the 2nd consecutive quarter of growth. On the full year, FY26 printed ₹179 Cr (+5.3%), and the 10-year compound rate is 4.1%.

FY26 profit ₹179 Cr (+5.3% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
4.1% a year over 10 years
Net profitYoY growth
31540%23720%1580.0%79−20%0−39%₹ Cr%₹1795.3%FY16FY21FY26
31540%23720%1580.0%79−20%0−39%₹ Cr%₹1795.3%FY16FY21FY26
Jun 26: ₹55.0 Cr (+12.2% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
2nd straight quarter of growth
Net profit (quarterly)YoY growth
73110%5575%3739%184.1%0−31%₹ Cr%₹5512.2%Sep 23Dec 24Jun 26
73110%5575%3739%184.1%0−31%₹ Cr%₹5512.2%Sep 23Dec 24Jun 26

Why profit moved: revenue contributed +7.8% and the margin +0.0 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +3.2% vs revenue +2.1%. Profit and revenue are moving roughly in step.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 180% of Relaxo Footwears Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹348 Cr of operating cash against ₹179 Cr of profit. After ₹221 Cr of capital spending, ₹127 Cr was left as free cash.

FY26: operating cash of ₹348 Cr against reported profit of ₹179 Cr, leaving free cash of ₹127 Cr after ₹221 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 180% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹348 Cr vs profit ₹179 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution.
180% of 3-year profit arrived as cash
Operating cashNet profitFree cash
5653761880−190₹ Cr₹348₹179₹127FY16FY21FY26
5653761880−190₹ Cr₹348₹179₹127FY16FY21FY26
FY26: CFO = 194% of profit (three-year rate 180%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
279%210%142%74%5.1%%194%FY16FY21FY26
279%210%142%74%5.1%%194%FY16FY21FY26

Why conversion sits at 180%: the cash cycle stretched 37 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.

Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Relaxo Footwears Ltd's cash conversion cycle runs 138 days in FY26, up from 101 days in FY21. Capital spending ran ₹685 Cr over the last 3 years. At FY26 sales of ₹2,702 Cr each day of that cycle holds about ₹7.4 Cr, so roughly ₹1,022 Cr sits inside the business at any moment.

FY26: debtors at 40 days, inventory at 184 days — roughly 6.1 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 138 days, looser than FY21's 101.

The full loop: cash goes out to suppliers and production on day 0; stock waits 184 days to sell; customers pay about 40 days after that; and suppliers themselves are paid at 87 days — netting out to the 138-day cycle.

In money terms: at FY26 sales of ₹2,702 Cr, each day of the cycle holds about ₹7.4 Cr — so the 138-day loop keeps roughly ₹1,022 Cr sitting inside the business at any moment.

FY26: a 138-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
+37 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
216164112597days138d184d40d87dFY14FY17FY20FY23FY26
216164112597days138d184d40d87dFY14FY20FY26

On the investment side: capital spending of ₹685 Cr over the last 3 fiscal years against ₹462 Cr of depreciation — building somewhat ahead of wear-and-tear. Capital work-in-progress stands at ₹97.0 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹221 Cr, work-in-progress ₹97.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
steady investment
CapexWork-in-progress
337253168840₹ Cr₹221₹97FY16FY18FY21FY23FY26
337253168840₹ Cr₹221₹97FY16FY21FY26

The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Relaxo Footwears Ltd earns a ROCE of 11% in FY26. Return on invested capital clears the cost of that capital by −4.5 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 6.6% net margin on 0.92× asset turns.

FY26 ROCE is 11%.

🚨 Why the return is what it is — the wiring (FY26): 6.6% net margin × 0.92× asset turns × 1.34× balance-sheet leverage ≈ 8.1% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 7.5% − 12.0% = a −4.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 11% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the full ladder
ROCEROIC (annual)WACC
32%25%19%12%5.8%%11%7.6%FY14FY20FY26
32%25%19%12%5.8%%11%7.6%FY14FY20FY26
Q4 FY26: ROCE 8.9% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
13%11%9.8%8.4%7.0%%8.9%7.4%Q1 FY24Q2 FY25Q4 FY26
13%11%9.8%8.4%7.0%%8.9%7.4%Q1 FY24Q2 FY25Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Relaxo Footwears Ltd carries total debt of ₹233 Cr against shareholder equity of ₹2,206 Cr as of Mar 26, a debt-to-equity of 0.11 — effectively unlevered. On the annual view that ratio went from 0.10 in FY22 to 0.11 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹233 Cr against shareholder equity of ₹2,206 Cr — a debt-to-equity of 0.11. On the annual view, debt-to-equity went from 0.10 (FY22) to 0.11 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹233 Cr at 0.11× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
2520.112×1890.106×1260.100×630.094×00.088×₹ Cr×₹2330.11×FY22FY24FY26
2520.112×1890.106×1260.100×630.094×00.088×₹ Cr×₹2330.11×FY22FY24FY26
Mar 26: debt ₹233 Cr, debt-to-equity 0.11 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
2520.122×1890.114×1260.105×630.096×00.088×₹ Cr×₹2330.11×Jun 23Sep 24Mar 26
2520.122×1890.114×1260.105×630.096×00.088×₹ Cr×₹2330.11×Jun 23Sep 24Mar 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of Relaxo Footwears Ltd moved a full percentage point over the last two years — the register is quiet. Domestic institutions moved +0.1 points over the same window, to 9.7%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Foreign institutions: −0.3 points over 8 quarters to 3.1%; Domestic institutions: +0.1 points over 8 quarters to 9.7%; Promoters: +0.0 points over 8 quarters to 71.3%.

Fiscal-year ends: promoters +0.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
77%57%37%17%−2.4%%71.3%3.0%9.7%15.9%Mar 24Mar 25Mar 26
77%57%37%17%−2.4%%71.3%3.0%9.7%15.9%Mar 24Mar 25Mar 26
A quiet register: no holder moved a full point in two years Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
77%57%37%17%−2.6%%71.3%3.1%9.7%15.9%Jun 23Dec 24Jun 26
77%57%37%17%−2.6%%71.3%3.1%9.7%15.9%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Relaxo Footwears Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Footwear
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Redtape LtdREDTAPE 69.3/100Favorable setup100% evidence ASLEEP 27.9/35 Revenue 19% · PAT 38.8% · OPM change 0 pp 100% evidence 18.0/25 ROCE 24.5% · OPM 17% 100% evidence 18.9/20 P/E 26× · PEG 0.76 100% evidence 4.5/20 RS sector -8.4% · RS bench -8.8% · 1Y -20.8%4 of 12 weeks ahead 100% evidence
Exact sum: 27.9 + 18 + 18.9 + 4.5 = 69.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -8.4% and the one-year return is -20.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
2Sreeleathers LtdSREEL 63.0/100Mixed-positive evidence72% evidence BREAKING OUT 27.9/35 Revenue 16.7% · PAT 56.9% · OPM change 7 pp 95% evidence 10.6/25 ROCE 7% · OPM 14.9% 95% evidence 12.0/20 P/E 23.5× · PEG — 50% evidence 12.5/20 RS sector — · RS bench 57.2% · 1Y —6 of 6 weeks ahead 25% evidence
Exact sum: 27.9 + 10.6 + 12 + 12.5 = 63 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3Campus Activewear LtdCAMPUS 60.4/100Mixed-positive evidence94% evidence BASING 21.8/35 Revenue 13.8% · PAT 31.6% · OPM change 0 pp 100% evidence 14.4/25 ROCE 21.2% · OPM 14% 100% evidence 11.7/20 P/E 42.5× · PEG 2.04 100% evidence 12.5/20 RS sector 12.1% · RS bench -13.1% · 1Y -21.2%0 of 10 weeks ahead 70% evidence
Exact sum: 21.8 + 14.4 + 11.7 + 12.5 = 60.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Metro Brands LtdMETROBRAND 50.6/100Mixed-positive evidence94% evidence BASING 14.6/35 Revenue 15.5% · PAT 14.1% · OPM change -1 pp 100% evidence 18.6/25 ROCE 20.1% · OPM 30% 100% evidence 4.9/20 P/E 63.1× · PEG 4 100% evidence 12.5/20 RS sector 7.3% · RS bench -10.2% · 1Y -23.7%0 of 10 weeks ahead 70% evidence
Exact sum: 14.6 + 18.6 + 4.9 + 12.5 = 50.6 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
5Mirza International LtdMIRZAINT 33.4/100Adverse evidence72% evidence 9.7/35 Revenue -9.3% · PAT 100% · OPM change -6.7 pp 95% evidence 3.4/25 ROCE -1.8% · OPM 2.4% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.3/20 RS sector -4.8% · RS bench -7.6% · 1Y -1.2%4 of 7 weeks ahead to 2026-08-09 100% evidence
Exact sum: 9.7 + 3.4 + 10 + 10.3 = 33.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Bata India LtdBATAINDIA 32.4/100Adverse evidence84% evidence ASLEEP 8.1/35 Revenue 1.9% · PAT -30.1% · OPM change 0 pp 100% evidence 13.0/25 ROCE 12.7% · OPM 21% 100% evidence 8.3/20 P/E 48× · PEG — 50% evidence 3.0/20 RS sector -20.9% · RS bench -21.2% · 1Y -47.8%0 of 10 weeks ahead 70% evidence
Exact sum: 8.1 + 13 + 8.3 + 3 = 32.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7Relaxo Footwears Ltdthis pageRELAXO 30.1/100Adverse evidence100% evidence ASLEEP 13.3/35 Revenue 2.1% · PAT 6.3% · OPM change 0 pp 100% evidence 11.6/25 ROCE 11.2% · OPM 15% 100% evidence 2.9/20 P/E 43.6× · PEG 6.15 100% evidence 2.3/20 RS sector -10.3% · RS bench -11.2% · 1Y -34.6%9 of 12 weeks ahead 100% evidence
Exact sum: 13.3 + 11.6 + 2.9 + 2.3 = 30.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Relaxo Footwears Ltd's share price today?

Relaxo Footwears Ltd trades at ₹325, −33.6% over the past year. The company is valued at ₹8,089 Cr. The stock sits at 40% of its 52-week range of ₹250–₹440, −13.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 6 weeks in. — as of 11 September 2026.

What were Relaxo Footwears Ltd's latest quarterly results?

Relaxo Footwears Ltd reported revenue of ₹705 Cr and net profit of ₹55.0 Cr for the Jun 26 quarter. Revenue rose 7.8% and profit rose 12.2% year on year. Earnings per share were ₹2.21. The operating margin was 15.0%, 0.0 pp higher than a year earlier. — as of 11 September 2026.

What is Relaxo Footwears Ltd's revenue?

Relaxo Footwears Ltd reported revenue of ₹705 Cr in the Jun 26 quarter, +7.8% year on year. For the full FY26 fiscal year, revenue was ₹2,702 Cr (−3.2%). Over the last 10 years revenue compounded at 4.9% a year. — as of 11 September 2026.

What is Relaxo Footwears Ltd's profit?

Relaxo Footwears Ltd earned ₹55.0 Cr of net profit in the Jun 26 quarter, +12.2% year on year — the 2nd straight quarter of growth. Full-year FY26 profit was ₹179 Cr. The operating margin ran 15.0% in the latest quarter. — as of 11 September 2026.

What is Relaxo Footwears Ltd's market cap?

Relaxo Footwears Ltd's market capitalisation is ₹8,089 Cr at a share price of ₹325. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.

What is Relaxo Footwears Ltd's P/E ratio?

Relaxo Footwears Ltd trades at a P/E of 43.6×, at the 5th percentile of its own 11-year range, against a long-run median of 67.1×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.

Does Relaxo Footwears Ltd pay a dividend?

Yes — Relaxo Footwears Ltd's dividend payout was 49% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.

Is Relaxo Footwears Ltd overvalued?

On its own history, Relaxo Footwears Ltd looks cheap: its P/E of 43.6× has been cheaper only 5% of the time in 11 years (long-run median 67.1×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.

Is Relaxo Footwears Ltd growing?

Yes — Relaxo Footwears Ltd is growing: latest-quarter revenue +7.8% year on year, profit +12.2%, and the margin +0.0 pp at 15.0%. The 10-year compound rates are 4.9% (revenue) and 4.1% (profit). The earnings engine currently reads: improving — as of 11 September 2026.

How is Relaxo Footwears Ltd performing?

Relaxo Footwears Ltd is in a confirmed uptrend, 6 weeks in. Its latest quarter's revenue rose 7.8% and profit rose 12.2% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 3 weeks. This describes what the data did, not a rating. — as of 11 September 2026.

What stage is Relaxo Footwears Ltd in?

Improving — profit growth bottomed 5 quarters ago at −13.4% and has held its recovery at +6.3%, ROCE holding at 11.1%. The read comes from the last 12 quarters of growth (revenue growth +2.2% latest, profit growth +6.3% latest, eps growth +6.0% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.

Is Relaxo Footwears Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 6 of stage 2), trading −13.6% versus its 200-day average and at 40% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.

Is Relaxo Footwears Ltd beating the market?

Not lately — on a trailing-13-week view Relaxo Footwears Ltd is currently behind the NIFTY 500 (3 weeks and counting; last ahead the week of 2026-08-21), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +68% against the NIFTY 500's +267% — behind the index over the full window. — as of 11 September 2026.

Will Relaxo Footwears Ltd's share price go up?

This page publishes no price forecast for Relaxo Footwears Ltd. What it measures instead: the share price is ₹325, the price is in a confirmed uptrend 6 weeks in. Its P/E of 43.6× sits at the 5th percentile of its own 11-year range. — as of 11 September 2026.

Who owns Relaxo Footwears Ltd?

Promoters hold 71.3% of Relaxo Footwears Ltd, foreign institutions 3.1%, domestic institutions 9.7% and the public 15.9% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.

Does Relaxo Footwears Ltd have too much debt?

No — Relaxo Footwears Ltd's debt-to-equity is 0.11, and operating profit covers the interest bill 16×. FY26 borrowings were ₹233 Cr against equity of ₹2,206 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.

What is Relaxo Footwears Ltd's capex?

Relaxo Footwears Ltd spent ₹685 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹221 Cr, with ₹97.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.

What is Relaxo Footwears Ltd's cash flow?

Relaxo Footwears Ltd generated ₹348 Cr of operating cash flow in FY26 and ₹127 Cr of free cash flow after ₹221 Cr of capital spending. Reported profit that year was ₹179 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.

Is Relaxo Footwears Ltd's profit real cash?

Yes — over the last 3 fiscal years, 180% of Relaxo Footwears Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹348 Cr against reported profit of ₹179 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 11 September 2026.

Where is Relaxo Footwears Ltd in its business cycle?

Relaxo Footwears Ltd's FY26 operating margin was 14.0%, against a 13-year band of 12.0%–21.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 15.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.

What could break the Relaxo Footwears Ltd story?

The sharpest disagreement: annual EPS moved +5.3% against a −33.6% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.

Is Relaxo Footwears Ltd a stock worth studying right now?

This is not investment advice. The machine read: Relaxo Footwears Ltd is coiled. The quarters are improving, yet the P/E sits at the 5th percentile of its own 11-year range — the business is moving before the market. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-11. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI